Robert Eferl
Impact in
- Cancer Research top 2%
- NF-κB Signaling Pathways
- Oncology top 1%
- Cytokine Signaling Pathways and Interactions
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- Bone health and treatments
Papers in
- Oncology 39
- Cytokine Signaling Pathways and Interactions 17
- Cancer-related Molecular Pathways 7
- Bone health and treatments 6
- Cancer Immunotherapy and Biomarkers 6
- Immunology 23
- Immune cells in cancer 9
- Immune Cell Function and Interaction 7
- interferon and immune responses 7
- Co-authors
- Erwin Friedrich Wagner (18 shared papers)Lukas Kenner (19 shared papers)Rainer Zenz (9 shared papers)Harald Scheuch (6 shared papers)Martina Rath (3 shared papers)Erwin Tschachler (2 shared papers)Astrid Hoebertz (6 shared papers)Peter E. Angel (3 shared papers)
- Journals
- Hepatology (5 papers)Gut (3 papers)The Journal of Cell Biology (3 papers)Gastroenterology (3 papers)OncoImmunology (3 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Robert Eferl
79 papers receiving 7.4k citations
Robert Eferl's Hit Papers
Peers
Comparison fields: 5 of 132
- Cancer Research 1.3k
- Oncology 2.2k
- Immunology 1.5k
- Molecular Biology 3.8k
- Hepatology 334
Countries citing papers authored by Robert Eferl
This map shows the geographic impact of Robert Eferl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Eferl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Eferl more than expected).
Fields of papers citing papers by Robert Eferl
This network shows the impact of papers produced by Robert Eferl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Eferl. The network helps show where Robert Eferl may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Eferl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | AP-1: a double-edged sword in tumorigenesis Hit paper breakdown → | 2003 | 1845 |
| 2 | 2005 | 510 | |
| 3 | 2005 | 447 | |
| 4 | 2003 | 418 | |
| 5 | 2007 | 294 | |
| 6 | 2019 | 239 | |
| 7 | 2003 | 234 | |
| 8 | 1999 | 231 | |
| 9 | 2004 | 182 | |
| 10 | 2008 | 177 | |
| 11 | 2008 | 172 | |
| 12 | 2004 | 171 | |
| 13 | 2009 | 153 | |
| 14 | 2012 | 146 | |
| 15 | 2009 | 145 | |
| 16 | 2015 | 138 | |
| 17 | 2018 | 137 | |
| 18 | 2015 | 124 | |
| 19 | 2017 | 113 | |
| 20 | 2012 | 106 |
About Robert Eferl
Robert Eferl is a scholar working on Oncology, Immunology, Cancer Research, Molecular Biology and Hepatology, having authored 80 papers that have together received 7.6k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (17 papers), Immune cells in cancer (9 papers), Bone Metabolism and Diseases (8 papers), Cancer-related Molecular Pathways (7 papers), Immune Cell Function and Interaction (7 papers), interferon and immune responses (7 papers), Bone health and treatments (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (2.2k citations), Immunology (1.5k citations), Molecular Biology (3.8k citations) and Hepatology (334 citations). Robert Eferl has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Erwin Friedrich Wagner, Lukas Kenner, Rainer Zenz, Harald Scheuch, Martina Rath, Erwin Tschachler, Astrid Hoebertz, Peter E. Angel, Roméo Ricci and Jean‐Pierre David. Their work appears in journals such as Hepatology, Gut, The Journal of Cell Biology, Gastroenterology and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.